Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). Microviable Team joins [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and Pilar Manrique, PhD, Research Scientist, will be attending the 8th Microbiome Movement - Drug Development Summit Europe which will take place from 30 January to 1 February 2024 [...]
Microviable Therapeutics will participate in Microbiome Connect USA that will take place from November 14th to 16th in Boston. Claudio Hidalgo Cantabrana, CEO at Microviable, will join a like-minded community of 300 scientists and entrepreneurs [...]
During 2023 Microviable Therapeutics has attended several leading events in the fields of microbiota, pharma and investment. In some cases we have participated as speakers with presentations and posters. This is the case of Microbiome [...]
The experts’ committee of the Princess of Asturias awards has decided to grant this year´s award for technical and scientific research to Jeffrey Gordon, Bonnie L. Bassler and E. Peter Greenberg, experts and pioneers in [...]
Last Tuesday, Microviable Therapeutics attended the talks of Bonnie L. Bassler and Peter Greenberg, 2023 Princess of Asturias of Scientific and Technical research awards. Both explained their work on the phenomenon of quorum sensing, the [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending HLTH 2023 event in Las Vegas (USA) from October 8th to 11th. HLTH 2023 is the preeminent event [...]
Claudio Hidalgo, CEO at Microviable, will be attending BioSpain 2023, one of the largest international biotechnology events in southern Europe, will take place from 26-28 September 2023 in Barcelona thanks to a coordinated collaboration of [...]
Microviable Therapeutics will be presenting at Farmaforum 2023 taking place on September 20th-21th at Madrid. The Microviable team will consist of Claudio Hidalgo, CEO of the company, and Noelia Martínez, R&D Director. Noelia Martínez will [...]
Microviable Therapeutics Research Scientist Pilar Manrique will be presenting at Microbiome Connect Europe 2023 taking place on July 5th-6th at Amsterdam. Pilar will discuss "A path to develop a donor-based microbiome therapeutic product". Microbiome Connect [...]